Trump’s choice of minister hit pharmaceutical companies

Biotechnology and the stock prices of pharmaceutical companies are falling, reports the Reuters news agency.

Credit rating company S&P’s index of companies in the biotechnology industry was down about 4.5 percent on Friday evening Finnish time.

In practice, the share price of all large pharmaceutical companies, such as Pfizer, GSK and Moderna, was falling.

The reason is that he will become president Donald Trump’s notification that that he intends to appoint anti-vaccine Robert F. Kennedy as Minister of Health.

Effects are reflected as far as the old continent. Shares of Pfizer’s partner Biontech plunged in Germany.

With the help of diet pills good result the price of the Danish manufacturer Novo Nordisk was also falling. Kennedy has criticized the aforementioned company Ozempic medicinebecause according to him, the drug intervenes in the consequences of the diet, but does not correct the source of the problem.

Kennedy’s line against processed food also caused the prices of convenience food and soft drink companies to decline.

Danish CFO of Bavarian Nordic Henrik Juuel commented the economic media Financial Timesillethat stock market reactions are “overreactions”.

He didn’t believe in Kennedy’s plans to reform the health administration.

“I don’t think anyone will allow that. There must be wise people there to help him.”